Stratton Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
$4.34M Sell
13,904
-2,951
-18% -$879K 0.53% 71
2015
Q3
$4.58M Buy
16,855
+4,470
+36% +$1.37M 0.52% 69
2015
Q2
$3.76M Sell
12,385
-6,291
-34% -$1.88M 0.16% 152
2015
Q1
$5.56M Sell
18,676
-6,244
-25% -$1.78M 0.23% 128
2014
Q4
$6.42M Sell
24,920
-2,449
-9% -$612K 0.26% 120
2014
Q3
$6.6M Sell
27,369
-1,561
-5% -$349K 0.3% 107
2014
Q2
$6.45M Buy
28,930
+2,563
+10% +$531K 0.27% 119
2014
Q1
$5.43M Sell
26,367
-8,045
-23% -$1.59M 0.25% 121
2013
Q4
$5.78M Buy
+34,412
New +$5.38M 0.27% 116
2013
Q3
Sell
-34,240
Closed -$4.32M 342
2013
Q2
$4.32M Buy
+34,240
New +$3.88M 0.25% 126

Other funds holding AGN

Stratton Management's AGN Position: Q4 2015 in Review

Stratton Management reduced its Allergan plc (AGN) stake by 18% in Q4 2015, selling an estimated $879K and leaving 13,904 shares worth $4.34M. The position accounts for 0.53% of the portfolio, ranked #71.

Stratton Management first reported a position in AGN in Q2 2013 and has held it in 10 quarters since. The position peaked at $6.6M in Q3 2014. 1,110 funds tracked by Wall St. Rank hold AGN as of Q4 2015.

  • Stratton Management held 13,904 shares of Allergan plc worth $4.34M as of Q4 2015.
  • Stratton Management sold 2,951 Allergan plc shares in Q4 2015, an estimated $879K.
  • Allergan plc made up 0.53% of Stratton Management's portfolio in Q4 2015, its #71 holding.
  • Stratton Management first reported a position in Allergan plc in Q2 2013 and has held it in 10 quarters since.
  • Stratton Management's Allergan plc position peaked at $6.6M in Q3 2014.
  • 1,110 funds tracked by Wall St. Rank held Allergan plc as of Q4 2015.

Based on Stratton Management's 13F filing for Q4 2015, filed 11 Feb 2016.